Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jan 1;53(1):40-47.
doi: 10.15586/aei.v53i1.1197. eCollection 2025.

Establishing the degree of control in patients with atopic dermatitis with the atopic dermatitis control tool (ADCT)

Alejandra Macías Weinmann  1 , Raquel Abigaíl López Henríquez  1 , Sandra Nora González Díaz  1 , Carlos Macouzet Sánchez  1 , Cindy Elizabeth de Lira Quezada  2
Affiliations
Observational Study

Establishing the degree of control in patients with atopic dermatitis with the atopic dermatitis control tool (ADCT)

Alejandra Macías Weinmann et al. Allergol Immunopathol (Madr). .

Abstract

Background: Atopic dermatitis (AD) is a disease of multifactorial etiology that affects the quality of life of those afflicted.

Objective: The degree of control of patients with AD over 12 years of age was determined with the Atopic Dermatitis Control Instrument (ADCT).

Material and methods: This observational, cross-sectional, descriptive study included patients with AD who were evaluated with a self-administered instrument, the ADCT. Pearson's Chi square and Student's t-tests were used for categorical variables. The association between continuous variables was analyzed with the Pearson and Spearman correlations.

Results: A total of 55 patients with AD were included-42 women (76.4%) and 13 men (23.6%). The median age was 24 years (12-63). Regarding the degree of disease control, it was adequate in 23 (41.8%) patients and inadequate in 32 (58.2%). The patient's sex, age, work activity, residence, and level of education were not statistically significant factors for the degree of control. The most prevalent comorbidity was allergic rhinitis with a higher percentage in those with adequate control (p = 0.049). Treatment with corticosteroids was associated with good disease control (p <0.001). A high positive correlation (r = 0.770, p < 0.001) was found between the SCORAD score and the ADCT score for symptom control. SCORAD and POEM scores showed a direct proportional relationship (r = 0.791; p < 0.001).

Conclusions: The ADCT allowed us to determine the degree of control of atopic dermatitis and develop treatment strategies.

Keywords: atopic; control; degree; dermatitis; disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflicts of interest with respect to research, authorship, and/or publication of this article.

References

    1. 1. Sánchez J, Páez B, Macías A, Olmos C, de Falco A. Guía de dermatitis atópica. Consenso de la Sociedad Latinoamericana de Alergia, Asma e Inmunología. Rev Alerg Mex. 2014;61(3):178–11. 10.29262/ram.v61i3.43 - DOI
    1. 2. Paras V, Silverberg J. Adult-onset atopic dermatitis: Characteristics and management. Am J Clin Dermatol. 2019;20(6):771–79. 10.1007/s40257-019-00453-7 - DOI
    1. 3. Pariser D, Simpson E, Gadkari A, Bieber T, Margolis D, Brown M, et al. Evaluating patient-perceived control of atopic dermatitis: Design, validation, and scoring of the atopic dermatitis control tool (ADCT). Curr Med Res Opin. 2020;36(3):367–76. 10.1080/03007995.2019.1699516 - DOI
    1. 4. Guevara Sanginés E, Pérez Rojas D, Nevárez Sida A, Aceves M, Barrón Tapia M, Abaroa Cantú F, et al. Costo anual de la atención médica de pacientes con dermatitis atópica moderada a grave en México. Estudio multicéntrico. Rev Alerg Mex. 2020;67(1):9–18. 10.29262/ram.v67i1.700 - DOI
    1. 5. Sandoval Ramírez E, del Rio B, del Río Chivardí J, Pietropaolo Cienfuegos D, Rosas Vargas M, Avila L, et al. Prevalence and associated risk factors for atopic dermatitis symptoms in Mexican children. World Allergy Organ J. 2012;5:S15–S16.10.1097/01.WOX.0000411791.20709.40 - DOI

Publication types

Substances